Comprehensive CBT (Cognitive Behavioral Therapy) Via reSET App

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-04

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being done to find out whether an app based cognitive behavior therapy called reSET improves the adherence to and outcome of buprenorphine treatment for opioid use disorder (OUD) in the setting of a Hub and Spoke implementation system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

reSET-O RCT (Randomized Controlled Trial)

NCT04129580

Opioid-use Disorder

COMPLETED NA

CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder

NCT04240093

Opioid-use Disorder Medication Adherence Health Care Utilization

COMPLETED NA

CBT4CBT for Office Based Buprenorphine

NCT03580902

Opioid-use Disorder

COMPLETED PHASE1/PHASE2

Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

NCT04850664

Opioid Use Disorder, Moderate Opioid Use Disorder, Severe Withdrawal Symptoms +2 more

UNKNOWN PHASE2

Coordinating Opioid Use Treatment Through Medical Management With Infection Treatment (Project COMMIT)

NCT04180020

Opioid-use Disorder

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Addiction Opioid-use Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

N/A at this time. This trial is a pilot study seeking an N of 15 participants. All participants will be assigned the "treatment," which is accessing an mobile app, re-SET, for cognitive behavioral therapy extension that is to be used with MAT (Buprenorphine only at this time).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

reSET

reSET is a mobile app created by Pear Therapeutics, Inc., which has previously been approved by the FDA.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* Starting outpatient treatment for OUD within the PACMAT Hub and Spoke system (either the Hub or one of the Spokes)
* Planning maintenance treatment with buprenorphine
* Willing to participate in the study
* Can read, write and comprehend English

Exclusion Criteria

* Planning an outpatient detoxification, or treatment other than buprenorphine maintenance (e.g. methadone maintenance, Vivitrol, or counseling with no medication)
* Judged by the evaluating physician or allied clinician to need a higher level of care (e.g. residential or inpatient treatment)
* Unwilling to participate in the study
* Under the age of 18
* Unable to read, write and comprehend English

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No